Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-06-05
1997-09-23
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514372, 548213, C07D23104, C07D27502
Patent
active
056705298
ABSTRACT:
Compositions comprising optionally substituted 3-isothiazolone derivative compounds, a metal nitrate, cupric (Cu.sup.2+) ion in ppm amounts in the form of an inorganic copper salt and water are described for preventing the formation of unsightly precipitations in these compositions during storage.
REFERENCES:
patent: 3870795 (1975-03-01), Miller et al.
patent: 5073582 (1991-12-01), LeSota et al.
Cheng Julie J. L.
Oswecki Jane C.
Richter Johann
Rohm and Haas Company
LandOfFree
Avoidance of precipitation in 3-isothiazolone formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Avoidance of precipitation in 3-isothiazolone formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Avoidance of precipitation in 3-isothiazolone formulations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1938808